FDA asks for study do-overs at two CROs due to data concerns
28 Sep 2021 //
FIERCEBIOTECH
Two Indian CROs under lens as United States raises data integrity issues
27 Sep 2021 //
ECONOMIC TIMES
Panexcell Clinical Laboratories: suspension of medicines over flawed studies
24 Jul 2020 //
EMA